Financial Information of Influx Healthtech Limited IPO
The Revenues from operations for the Period ended on Mar 31, 2025, 2024 and 2023 were ₹
10,498.67 Lakh, ₹ 10,001.60 Lakh and ₹
7,605.65 Lakh. The EBITDA for the Period ended on Mar 31, 2025, 2024 and 2023 were ₹ 2,070.45 Lakh, ₹
1,700.65 Lakh and ₹ 1,072.34 Lakh. The Profit after Tax for the Period ended on Mar 31, 2025, 2024 and 2023 were were ₹
1,336.60 Lakh, ₹ 1,112.80 Lakh and ₹ 719.63 Lakh respectively. This indicates a steady growth in financial performance.
| Period Ended | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 |
|---|---|---|---|
| Reserve of Surplus | 1,815.00 | 2,275.44 | 1,162.65 |
| Total Assets | 7,029.91 | 4,110.31 | 2,830.42 |
| Total Borrowings | 21.92 | 32.48 | 79.85 |
| Fixed Assets | 1,872.50 | 1,370.60 | 629.64 |
| Cash | 191.06 | 360.56 | 354.71 |
| Net Borrowing | -169.14 | -328.08 | -274.86 |
| Revenue | 10,498.67 | 10,001.60 | 7,605.65 |
| EBITDA | 2,070.45 | 1,700.65 | 1,072.34 |
| PAT | 1,336.60 | 1,112.80 | 719.63 |
| EPS | 7.36 | 6.13 | 3.96 |
Note 1:- RoE, ROCE & RoNW calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Note 2:- Pre EPS and Post EPS calculation in KPI is based (Profit/Loss for the Year) on 31st Mar, 2025 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Copyright @2020 Design & Developed by Info Web Software